Literature DB >> 2984039

Aminopyridine-sensitivity of spinal cord white matter studied in vitro.

J D Kocsis.   

Abstract

Sections of dorsal columns of the spinal cord were removed from rats of various ages and studied in a sucrose gap chamber. The potassium channel blocking agent, 4-aminopyridine (4-AP), led to a pronounced increase in the area of the compound action potential of immature dorsal column axons. During the course of maturation this effect was attenuated but not lost. Occlusion experiments indicate that the 4-AP-elicited increase in area of the response was likely the result of multiple action potential discharge, an effect also present in dorsal root but not ventral root fibers (Bowe et al. 1985). These results indicate that the 4-AP-elicited changes in action potential characteristics previously described for sensory fibers in the peripheral nervous system are also present in the central nervous system extensions of these axons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984039     DOI: 10.1007/bf00237849

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  12 in total

1.  Potential clamp experiments on myelinated nerve fibres from alloxan diabetic rats.

Authors:  T Brismar
Journal:  Acta Physiol Scand       Date:  1979-03

2.  Sodium and potassium channels in regenerating and developing mammalian myelinated nerves.

Authors:  J M Ritchie
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-06-22

3.  A quantitative description of membrane currents in rabbit myelinated nerve.

Authors:  S Y Chiu; J M Ritchie; R B Rogart; D Stagg
Journal:  J Physiol       Date:  1979-07       Impact factor: 5.182

4.  Maturation of mammalian myelinated fibers: changes in action-potential characteristics following 4-aminopyridine application.

Authors:  J D Kocsis; J A Ruiz; S G Waxman
Journal:  J Neurophysiol       Date:  1983-08       Impact factor: 2.714

5.  The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.

Authors:  H Bostock; T A Sears; R M Sherratt
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

6.  Differences between mammalian ventral and dorsal spinal roots in response to blockade of potassium channels during maturation.

Authors:  C M Bowe; J D Kocsis; S G Waxman
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-05-22

7.  Ligature-induced injury in peripheral nerve: electrophysiological observations on changes in action potential characteristics following blockade of potassium conductance.

Authors:  S G Waxman; J D Kocsis; D L Eng
Journal:  Muscle Nerve       Date:  1985-02       Impact factor: 3.217

8.  Potential clamp analysis of membrane currents in rat myelinated nerve fibres.

Authors:  T Brismar
Journal:  J Physiol       Date:  1980-01       Impact factor: 5.182

9.  Regenerating mammalian nerve fibres: changes in action potential waveform and firing characteristics following blockage of potassium conductance.

Authors:  J D Kocsis; S G Waxman; C Hildebrand; J A Ruiz
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-12-22

10.  Long-term regenerated nerve fibres retain sensitivity to potassium channel blocking agents.

Authors:  J D Kocsis; S G Waxman
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

View more
  3 in total

1.  Axonal GABA receptors are selectively present on normal and regenerated sensory fibers in rat peripheral nerve.

Authors:  R B Bhisitkul; J E Villa; J D Kocsis
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

2.  Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers.

Authors:  Sofia Rodríguez-Rangel; Alyssa D Bravin; Karla M Ramos-Torres; Pedro Brugarolas; Jorge E Sánchez-Rodríguez
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

3.  A Novel Approach for Studying the Physiology and Pathophysiology of Myelinated and Non-Myelinated Axons in the CNS White Matter.

Authors:  Lijun Li; Alexander A Velumian; Marina Samoilova; Michael G Fehlings
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.